Abstract Interstand crosslinks (ICLs) are DNA lesions where the bases of opposing DNA strands are covalently linked, inhibiting critical cellular processes such as transcription and replication. Chemical agents that generate ICLs cause chromosomal abnormalities including breaks, deletions and rearrangements, making them highly genotoxic compounds. This toxicity has proven useful for chemotherapeutic treatment against a wide variety of cancer types. The majority of our understanding of ICL repair in humans has been uncovered through analysis of the rare genetic disorder Fanconi anemia, in which patients are extremely sensitive to crosslinking agents. Here, we discuss recent insights into ICL repair gained using new repair assays and highlight the role of the Fanconi anemia repair pathway during replication stress.
Introduction to ICLs
Interstand crosslinks (ICLs) prevent the separation of the Watson and Crick strands of the double helix, inhibiting critical cellular processes such as transcription and replication. ICLs cause a range of structural changes in the DNA. Platinum compounds, such as cisplatin, generate large structural distortion to the DNA. These distorting lesions are recognized directly by the DNA repair machinery. Other ICL inducing agents, such as mitomycin C, do not generate distorting lesions [86, 103] . Instead, these non-distorting ICLs act as barriers to processes that require translocation along the DNA and their detection depends on the genomic transactions that occur in their vicinity. For example, in cells undergoing replication, the replication machinery serves as the sensor for non-distorting ICLs. In non-proliferating cells (such as postmitotic differentiated cells, quiescent or senescent cells) non-distorting ICLs are detected through the transcription machinery encountering ICLs present in actively transcribed genes (transcription-coupled ICL repair). In mammalian cells, ICL repair is generally considered to be predominantly replication-dependent, although ICL repair in G1 does occur [8, 85, 90] . In this review, we discuss the role of the Fanconi Anemia pathway in the detection and repair of ICL lesions in mammalian cells and Xenopus cellfree extracts. For reviews of ICL repair in lower organisms, please see [53, 57, 86] . patients are extremely sensitive to crosslinking agents [19, 31] . Fanconi anemia (FA) is a rare disease associated with congenital abnormalities, progressive bone marrow failure and a predisposition to cancers, such as acute myeloid leukemia and squamous cell carcinomas [4] . Cells derived from FA patients are severely sensitive to DNA crosslinking agents, including mitomycin C(MMC), psoralen-UV-A, cisplatin (CDDP) and diepoxybutane (DEB) [18] . The ability of DEB to induce chromosomal breakages in FA lymphocytes serves as a functional diagnostic test for FA [6] .
The underlying gene mutations responsible for FA have been identified through functional complementation of ICL sensitivity, positional cloning, biochemical purification, and more recently through direct sequencing of candidate genes [46, 113] . Currently, fourteen FA genes have been identified (FANCA, B, C, D1, D2, E, F, G, I, J, L, M, N, P) (Table 1 ). This number excludes the RAD51 paralog, RAD51C, where inactivation caused a FA-like disorder lacking symptoms of bone marrow failure [112] ( Table 2 ). The FA pathway consists of three distinct functional groups: the FA core complex (FANCA, B, C, E, F, G, L, M and N), the ID complex (FANCI/FANCD2) and the downstream effector proteins (FANCD1, J, N and P) ( Table 1 ). The FA core complex functions as an ubiquitin ligase that monoubiquitinates both ID complex proteins FANCD2 and FANCI. Monoubiquitination of FANCD2 and FANCI is critical for their retention on chromatin and localization at nuclear foci with the downstream BRCArelated FA effector proteins (FANCD1, J, N and P) [25, 101, 105, 108] . These downstream components are not required for FANCD2/I monoubiquitination and instead participate directly in the final stages of ICL repair via homologous recombination (Fig. 1) .
The FA core complex
The FA core complex consists of eight FA proteins and three Fanconi anemia-associated proteins: FAAP20, FAAP24 and FAAP100 [47, 60, 73, 102] (Table 2) . For more comprehensive reviews on the FA core complex, please see [19, 31, 73] . Activation of the FA pathway in response to ICLs requires the targeting components of the FA core complex, FANCM and FAAP24 [12, 48] . FANCM is the only FA core component with DNA binding activity. In vitro, FANCM can specifically bind to Holliday junctions and replication fork structures [26, 27] . Once bound to chromatin, FANCM/FAAP24 recruits the FA core complex through a direct interaction between FANCM and FANCF ( Fig. 1) [20] . FANCM is a highly conserved protein, with an ortholog, Hef1 (helicase associated Chromosomal locations were identified in Ensembl and associated proteins were collected from UniProtKB endonuclease for forked-structures), present in Archaebacteria [69, 76] . FANCM is the only core complex member that is not strictly required for the stability of the complex and as a result FANCD2 is still partially monoubiquitinated in its absence [102] . FANCM/FAAP24 instead are required for the chromatin localization of the core complex and resistance to ICLs [12, 48, 102] . The FA accessory protein, FAAP20, is the newest member of the FA core complex. It was identified as a direct interactor of FANCA and is required for the integrity of the FA core complex and for crosslink repair [2, 47, 60] . FAAP20 contains a RAD18-like ubiquitin-binding zincfinger 4 domain that appears to be dispensable for FANCD2 monoubiquitination and crosslink repair [60] . Instead, the UBZ4 domain of FAAP20 binds to the monoubiquitinated form of Rev1, an important component of the error-prone Translesion Synthesis pathway (TLS), a key DNA damage tolerance pathway (discussed in more detail below). FAAP20 stabilizes Rev1 nuclear foci and provides a critical link between the FA core complex and TLS polymerase activity that may explain why FA core-deficient cell lines are hypomutable for point mutations [47, 71, 89] .
The FA core complex ubiquitinates FANCI and FANCD2 through its catalytic subunits, FANCL (the E3 ligase) and These genes represent crucial FA pathway members for which patient mutations have not been found with the exception of Rad51C. Chromosomal locations were identified in Ensembl and associated proteins were collected from UniProtKB
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UBE2T (the ubiquitin E2 ligase) [64, 68] . Insights into the ubiquitination of the ID complex have come from reconstructing the ubiquitination of FANCD2 in vitro; various forms of DNA including single-stranded, double-stranded and branched DNA are capable of stimulating FANCD2 monoubiquitination in vitro [95] . Notably, the DNA-binding activity of FANCI is required for the DNA-dependent stimulation of FANCD2 monoubiquitylation [95] . FANCI also imparts specificity to the ubiquitination reaction by limiting monoubiquitination to K561 of FANCD2 [3] . It was also reported that monoubiquitinated PCNA stimulates FANCD2 and FANCI monoubiquitination in vitro, strengthening independent findings that RAD18-mediated monoubiquitination of PCNA is an important regulator of the ID complex [29, 116] . In vivo, it is still unclear what factors regulate and participate in targeting the core complex to its substrates, FANCD2 and FANCI. One possibility is that FANCE bridges the FA core complex and FANCD2 [88] .
The FANCI/FANCD2 (ID) complex
Monoubiquitination of the ID complex serves as a marker for activation of the FA core complex. The monoubiquitination of both FANCI (K523) and FANCD2 (K561) enables the complex to associate with chromatin through an unknown mechanism [21, 25, 101, 105, 108, 109] . Monoubiquitination of the ID complex can be induced by numerous types of DNA damage in addition to ICLs, including ionizing radiation, ultraviolet radiation and replication stress generated by inhibitors of replication, such as hydroxyurea and aphidicolin, as well as endogenous sources of replication stress such as re-replication [25, 40, 120] . Until recently it was unclear whether FANCD2 and FANCI contained any additional domains other than their monoubiquitination sites that were important for promoting DNA repair. Both FANCI and FANCD2 contain EDGE motifs (defined by the EDGE amino acid sequence), which is a cluster of acidic residues, essential for the correction of MMC sensitivity in FA-I or FA-D2-deficient fibroblasts [15, 75] . The precise role of the EDGE motif in DNA repair is unclear but it appears to act downstream of FANCI/FANCD2 monoubiquitination and may participate in recruiting additional repair factors to ICLs, or alternatively may be a critical structural component of both proteins [15] .
The crystal structure of the unmodified ID complex was recently solved providing much needed structural insight into how these proteins interact [43] . The structure demonstrated that the two proteins interact in an antiparallel manner, with the regulatory monoubiquitination sites mapped to the interface of the complex, suggesting that monoubiquitination occurs on monomeric proteins or an opened complex. Since this structure does not include the ubiquitin modifications, it is still unclear what role these modifications play in the assembly of the ID complex. Given their location in this complex, though, it suggests that they may serve to stabilize the ID heterodimer.
Fan1
Ubiquitination of the ID complex not only serves to localize the complex to chromatin, it also plays a key role in the repair process. The structure specific endonuclease, FAN1 (FANCD2-associated nuclease), contains an aminoterminal ubiquitin-binding zinc-finger (UBZ) domain that targets FAN1 to monoubiquitinated FANCD2 (Fig. 1) [51, 61, 65, 100, 104] . FAN1 possesses 5 0 flap endonuclease activities and FAN1 recruitment to FANCD2 is required for resistance to ICLs induced by MMC and cisplatin. Precisely how FAN1 contributes to ICL repair is unclear and remains an interesting subject for future investigation using defined ICL substrates.
Usp1
Monoubiquitination of the ID2 complex is dynamic, with deubiquitylation playing a critical role in ICL repair. Both FANCI and FANCD2 are deubiquitylated by the ubiquitinspecific protease, USP1 [84] . Deubiquitination of the ID complex is crucial for ICL repair, with loss of USP1 resulting in ICL sensitivity and increased genomic instability [42, 79, 87] . Interestingly, USP1 knockout mice display a FA-like phenotype [49] . In addition to its role in the FA pathway, USP1 also deubiquitinates a second monoubiquitinated substrate, PCNA, inhibiting repair through the TLS pathway [41] . Therefore, USP1 may play an important role in coordinating DNA repair by promoting the FA pathway and inhibiting the TLS pathway.
USP1 activity is under tight control regulated by multiple pathways. The first of these pathways acts directly on the enzymatic activity of USP1, which is stimulated by binding to a co-factor, USP1 associated factor 1 (UAF1), also known as WDR48 [14] . Secondly, USP1 expression is repressed by p21 upon exposure to DNA damaging agents. In the absence of p21 the persistent expression of USP1 can interfere with the accumulation of FANCD2 and FANCI monoubiquitination [93] . Finally, two separate pathways target the USP1 protein for degradaton. Upon UV DNA damage, USP1 is auto-cleaved and degraded by the proteasome [41] . USP1 protein levels are also regulated in a cell-cycle-dependent manner through the APC/C Cdh1 ubiquitin ligase, which maintains low levels of USP1 in G1 [16, 17] . The activity and tight regulation of USP1 ensures that both the FA and TLS repair pathways function correctly to maintain genome stability.
ICL repair
Until recently, it has been difficult to study the repair of ICL lesions exclusively since many crosslinking agents also generate intra-strand crosslinks and other forms of DNA damage. For this reason, strategies to introduce sequence specific synthetic ICLs into mammalian cells and cell-free Xenopus extracts have been developed to study ICL repair and checkpoint activation [8, 50, 92, 98] . These approaches have provided insight into how different ICL lesions are detected and repaired.
As mentioned previously, ICL lesions can be simplified into two classes: lesions that distort the DNA helix considerably, such as psoralen or cisplatin, and lesions that are less distorting (non-distorting) MMC and nitrogen mustards ICLs. The degree of helix distortion influences how the ICL is recognized and the repair pathways utilized [103] . The chemical structures of common chemotherapeutic ICL agents and their impact on the DNA helix have been discussed in detail elsewhere [36, 86] . Distorting ICL lesions are repaired through both replication-dependent and -independent pathways [8, 98] . In contrast, non-distorting lesions are primarily considered to be repaired through replicationdependent pathways [50, 92] . The replication-dependent repair of ICLs is performed using the error-free homologous recombination (HR) pathway. Since cells in G1/G0 have not yet acquired sister chromatids, they are forced to repair ICL lesions using the error-prone recombination-independent pathway, which employs nucleotide excision (NER) and translesion synthesis (TLS) repair pathways [94, 114, 118] .
Replication-independent ICL repair
In mammalian cells, ICL repair is primarily considered to be a replication-dependent process, therefore the majority of studies have focused on understanding this pathway. However, there is growing interest in how ICLs are repaired in a replication-independent manner, since replication-independent repair is likely to be crucial for the tolerance of non-dividing or terminally differentiated cells to ICLs.
Many reports of replication-independent repair exist, yet the repair pathway remains poorly defined [8, 78, 94, 98] . Replication-independent ICL repair occurs in two stages (Fig. 2a) . First, the NER pathway proteins unhook and excise the crosslink [78] . Second, the TLS pathway performs DNA repair synthesis [37] . Of the NER proteins, XPA and XPC are known to be required for the recruitment of the FA core component, FANCA, to ICLs [98] . This places XPA and XPC upstream of the FA pathway in the detection of ICLs, suggesting that the FA core complex is recruited to an ICL repair intermediate generated by the NER pathway [98] . How the FA pathway participates in replication-independent ICL repair pathways is still unclear.
Elegant research from the Gautier laboratory using both Xenopus egg extracts and mammalian cells revealed that the Fanconi pathway performs a critical replication-independent checkpoint signaling function in response to ICLs [8] . Using a site-specific ICL lesion and monitoring DNA damage signaling under restrictive replication conditions, it was demonstrated that the FA pathway acts upstream of ATR activation. This is surprising since ATR activation is achieved when RPA coated ssDNA is generated in response to uncoupling of the DNA helicase and the replisome [10, 121] . Moreover, ATR and RPA were previously shown to be important for FANCD2 monoubiquitination [5] . The study from the Gautier laboratory also concluded that replication-independent (and replication-dependent) ICL repair involves extensive DNA synthesis, consistent with models implicating translesion synthesis polymerases in ICL repair [8] .
Translesion synthesis (TLS)
TLS is a major DNA damage tolerance mechanism whereby alternative error-prone TLS polymerases bypass DNA lesions that would otherwise cause replication arrest and cell death [23] . TLS Polymerases possess low fidelity and can introduce mutations when replicating undamaged DNA templates; therefore they must be tightly regulated. Dysregulation of these error-prone enzymes can cause genomic instability and tumorigenesis [7, 42, 54] . PCNA, the replicative sliding clamp, recruits TLS polymerases to DNA lesions [56, 91] . The Y-family of polymerases contains two domains important for their interaction with PCNA. The first of these domains is the PCNA interacting motif or PIP box [32, 33] , which has the consensus sequence Q-X-X-(u)-X-X-(A)-(A), where (X) can be any residue (u) represents hydrophobic residues (I, L, M) and (A) represents residues with aromatic side chains (e.g., F, Y) [66, 115] . Importantly, the PIP box present in Y-family polymerases has relatively low affinity for PCNA in comparison to the p21 PIP box [35, 42] .
The majority of the binding affinity for PCNA comes from the second PCNA binding domain found in Y-family TLS polymerases, their ubiquitin-binding domains (UBM or UBZ domains). These domains interact with ubiquitinated PCNA to strengthen their interaction and facilitate
The Fanconi anemia pathway in replication stress and DNA crosslink repair 3967 the switch between replicative and TLS polymerases [9, 44] . Since PCNA is monoubiquitinated by Rad6-Rad18 at sites of stalled replication forks, this enables TLS polymerases to be recruited specifically to where they are most needed [38, 44] . In both yeast and mammalian cells, studies specifically focused on replication-independent ICL repair have clearly demonstrated Rad18-dependent monoubiquitination of PCNA is necessary for the recruitment of polymerase f to bypass ICLs [94, 99] . It is unclear whether PCNA monoubiquitination performs a similar role during replication-dependent ICL repair.
Replication-dependent ICL repair
The majority of ICL repair in actively dividing cells is coupled to DNA replication. This was classically demonstrated in synchronized human fibroblasts, where ICL repair occurred exclusively during S-phase, regardless of which cell-cycle phase the ICL was induced [1] . In order to discuss replication-dependent ICL repair, it is important to provide a brief overview of DNA replication licensing and initiation. In human cells, genome replication begins at tens of thousands of replication origins distributed throughout the genome [67] . Failure to initiate replication from a sufficient number of sites would leave regions of the genome unreplicated prior to mitosis. DNA replication licensing occurs in G1 with the assembly of pre-replicative complexes (preRCs), consisting of Cdc45, MCM2-7 and the GINS (collectively referred to as the CMG complex) at origins of replication. The pre-RCs are recruited by the origin recognition complex (ORC), Cdc6 and Cdt1. Subsequent phosphorylation of the Pre-RC by two S-phase promoting kinases, the cyclin-dependent (CDK) and Cdc7-Dbf4 (DDK), facilitates origin unwinding and the recruitment of the DNA polymerases and additional accessory factors, collectively known as the replisome complex [96, 119] .
The MCM complex is an important component of the replisome and functions as the replicative helicase necessary for both origin unwinding and replication fork progression [52, 58, 107] . The MCM complex unwinds the Fig. 2 Replication-dependent and replication-independent ICL repair pathways. a Replication-independent ICL repair. The ICL is recognized and unhooked by the NER pathway. TLS polymerase synthesis passed the unhooked ICL filling the gap generated by the unhooking. The ICL remnant is excised and repair is complete. b Replicationdependent ICL repair. Replication forks converge towards the ICL. The replication forks stall 20-40 nucleotides before the ICL. Then the leading strand of one fork advances towards the ICL and pauses 1 nucleotide from the ICL. Dual incisions are made on the non-template strand and a TLS polymerase extends past the unhooked ICL. The ICL remnant is removed and HR repairs the double strand break parental DNA duplex ahead of the replication fork, providing the single stranded DNA template for the DNA polymerases of the leading and lagging strands [24] . Since the MCM complex is positioned ahead of the replication fork, it is likely to be the first replisome component to encounter ICL lesions during DNA replication. This is supported by the enrichment of MCM7 at a site-specific psoralen crosslink [98] . It will be interesting to determine whether MCMs play an important role in signaling and/or recruitment of repair proteins to ICLs, although admittedly, given their role in DNA replication, it will be difficult to separate these functions.
Detailed models of replication-dependent ICL repair are beginning to emerge from the use of site-specific ICL templates in Xenopus extracts (Fig. 2b) . In this cell-free system, two replication forks converge on the ICL, with the leading strand polymerases initially pausing 20-24 nucleotides from the crosslink [92] . This distance is likely dictated by the inherent size of the replisome's footprint (including polymerase ? CMG complex) on DNA. The lagging strand polymerases were located at a greater and more variable distance from the lesion. After the initial fork pause, lesion bypass is initiated when the leading strand of a single fork advances to within 1 nucleotide of the ICL lesion. A dual incision process surrounding the ICL then unhooks the parental strands, and TLS incorporates a nucleotide across from the ICL lesion in a polymerase f-dependent process. Both the incision step and the insertion of a nucleotide opposite the ICL lesion is mediated by FANCI and FANCD2, since these events are absent when the ID complex is immunodepleted from extracts [50] .
Once the ICL is unhooked and the nucleotide opposite the lesion is inserted, the leading strand is extended and ligated to the first downstream Okazaki fragment. The final stage of ICL repair restores the broken sister chromatids (generated by the incision step) using the restored sister as a template for homologous recombination (Fig. 2a) . The repair of the broken chromatid by homologous recombination is Rad51-dependent with Rad51 binding to the ICL independently of the ID complex and prior to the formation of the double stranded DNA break [62] .
Overall, the convergent replication model differs from earlier models that suggested a single replication fork collides with the ICL lesion [83] . The small size of the plasmid used in these studies may not accurately reflect the repair scenario on chromosomal DNA, where the average replicon is 100-120 kb [67] . However, it is very likely that additional origins are fired within replicons containing ICL lesions. In any case, ICL repair was recently shown to occur whether one or two forks reached the ICL [55] . Mammals possess 15 unique DNA polymerases and from these, Pol f and Rev1 standout as the most important for ICL repair [37] . Although, there may also be requirements for additional TLS polymerases since studies have demonstrated roles for other TLS polymerases during crosslink repair including Pol m, Pol j and Pol g [37, 70, 72, 74, 99] . A remaining challenge will also be to determine the identity of the structure specific nuclease required for the dual incisions. A number of endonucleases have been implicated in the incision events of ICL repair including XPF-ERCC1, MUS81-EME1, SLX1-SLX4 and the Fanconi anemia-associated nuclease 1 (FAN1). The biochemical activities of these nucleases and their possible roles in ICL repair have been discussed elsewhere [13, 97] .
In contrast to the detailed analysis of ICL repair obtained in cell-free Xenopus extracts (described above) up until recently, it has been difficult in mammalian cells to demonstrate a direct role for the FA pathway in HR, using the classic I-Sce endonuclease HR assay. Deficiency in either the FA core or ID complexes in this assay leads to a relatively mild HR defect compared to downstream FA pathway components, such as BRCA2 [77, 82] . Recently, an improved assay specific for ICL-induced HR repair has been used successfully to demonstrate a defect in ICL induced HR repair in a FANCA patient cell line. Importantly, this repair defect was only observed when the reporter was able to replicate [81] . Using this improved assay to study ICL-induced HR repair in mammalian cells may provide further insights into replication-independent and replication-coupled ICL repair.
FA pathway and replication stress
In addition to its role in ICL repair, the FA pathway also contributes to the maintenance of genome stability by protecting against replication stress. ICL lesions may be viewed as a severe form of replication stress. The FA pathway is important for maintaining genome stability in response to many forms of replication stress, including damaging agents (such as aphidicolin (APH) or hydroxyurea), and endogenous sources of replication stress (including re-replication, oncogene induced replication stress (E7 oncoprotein protein expression) and dysregulation of error-prone polymerases) [25, 40, 42, 106, 120] . In particular, the FA pathway protects specific regions of the genome, termed common fragile sites, which display gaps and breaks on metaphase chromosomes in response to replication stress [11, 40, 80] . What makes these regions ''fragile'' is not entirely clear; the consensus is that these regions are inherently difficult to replicate.
There are two main theories as to why fragile sites are difficult to replicate. The first suggests that fragile sites possess structurally distinct properties including CGG expansions and AT-rich repeats that can form secondary structures (when unwound by the DNA helicase), such as hairpins or cruciform structures making them vulnerable to replisome stalling and collapse [22, 34] . The second theory suggests that factors affecting replication dynamics in these regions, including the organization and selection of replication origins, makes these sites fragile. Fragile site are often located within late replicating regions that possess a low density of replication origins, and therefore they are prone to incomplete replication in response to replication stress [59] . These two theories are not necessarily mutually exclusive and each or both maybe relevant to a particular fragile site.
Replication stress induced DNA breaks at fragile sites are particularly important since chromosome breakage and rearrangement at common fragile sites are early events in tumorigenesis [22] . Rearrangements at fragile sites also inactivate their associated genes. In the case of FRA3B and FRA16D, both reside within large tumor suppressor genes, FHIT and WWOX [22] . These DNA breaks at fragile sites are thought to arise when incompletely replicated regions are hyper-condensed during mitosis. Recently, the formation of mitotic double strand breaks in response to replication stress was shown to be dependent on the condensin subunit SMC2, which is required for the mechanical stability of condensed chromatin [30, 63, 111] . The SMC2 dependence for mitotic DSBs strongly suggests that mitotic chromosome condensation may trigger the DSB formation at fragile sites. Interestingly, both FANCI and FANCD2 localize to fragile sites during mitosis [11, 80] . This localization may be important for protecting these sites from condensation induced breakage or may facilitate their repair after mitosis.
Future perspectives
Much of what we know about ICL repair in mammalian cells has come from investigating the FA pathway. In this respect, there is still a lot to be learned about key steps within this pathway that contribute to the repair of ICLs. Understanding how ICLs are repaired will improve the use of ICL inducing agents in cancer treatment [20] .
Activation of the FA pathway
How is the interaction between the FA core complex and the ID complex regulated? FANCE directly binds to FANCD2 and it has been suggested that this interaction is the bridge between the FA core complex and FANCD2 [88] . This finding pre-dates the discovery of FANCI and many of the core complex components, as well as their accessory proteins. It will be interesting to re-investigate whether FANCE-FANCD2 is the only direct interaction between these two complexes.
How does monoubiquitination of the ID complex facilitate its association with chromatin? It is possible that ubiquitin-binding domains within unknown proteins associated with chromatin recruit the monoubiquitinated ID complex onto chromatin. This may specifically involve monoubiquitinated FANCI since FANCD2 monoubiquitination was shown to bind the FAN1 nuclease [51, 61, 65, 100, 104] .
The FA pathway and DNA Replication
The coordination between the FA pathway and DNA replication is still unclear. There is an increasing amount of evidence linking replisome components with members of the FA pathway. For example, PCNA interacts with FANCD2, and is thought to function as a platform to facilitate the mono-ubiquitination of FANCD2 [29, 39] . The FA core complex component, FANCF, physically interacts with PSF2, a member of the GINS complex involved in both the initiation and elongation steps of DNA replication [110] . These interactions potentially places the FA core and ID complexes at the replisome which could have important implications for how the FA pathway is activated in response to fork stalling at ICLs and other DNA damaging lesions. A better understanding of how the FA pathway protects against replications stress is also needed. The FA pathway may protect cells from replication stress by participating in the activation/regulation of dormant origin firing. The activation of dormant origins is a major pathway protecting cells from replication stress and contributes to the recovery of stalled replication forks [28, 45, 117] . Currently, how these back up origins are regulated is unclear and it will be interesting to determine whether the FA pathway participates in their selection.
In summary, continued analysis of the Fanconi anemia pathway will provide valuable knowledge on how cells respond to ICLs and other forms of replication stress. The recent development of defined ICL substrates and their use in mammalian cells and Xenopus extracts has provided an extremely detailed model of the FA pathway's role in ICL repair. The challenge remains to use this knowledge to improve on current therapies for Fanconi anemia patients.
